Table 1.
The MHC I Epitope Prediction, HLA Coverage, and Percent Conservancy of Top L1 and L2 HPV 52 Epitopes
| No | Sequences | Allele | HPV type conservansy | persen conservansy |
|---|---|---|---|---|
| 1 | LPDPNKFGF | HLA-B*35:01, HLA-B*53:01, HLA-B*07:02, HLA-B*51:01, HLA-B*08:01 | HPV39,68 (77.78%); HPV18,45,51,56,59,66,70 (88.89%); HPV52,16,31,33,34,35,58 (100%) | 100.00% (16/16) |
| 2 | VLVPKVSGL | HLA-A*02:03, HLA-A*02:01, HLA-A*02:06, HLA-B*08:01 | HPV45, 59 (55.56%); HPV31, 34, 35 (77.78%); HPV16, 33 (88.89%); HPV31, 58 (100.00%) | 56.25% (9/16) |
| 3 | YVSRTSIYY | HLA-A*01:01, HLA-B*35:01, HLA-A*30:02, HLA-A*26:01, HLA-B*15:01, HLA-A*68:01, HLA-A*11:01, HLA-B*58:01, HLA-A*03:01 | HPV51, 68 (66.67%); 16,18,31,34,35,39,56,59,66,70 (77.78%); HPV45 (88.89%); 52, 33, 58 (100%) | 100.00% (16/16) |
| 4 | FVTVVDTTR | HLA-A*68:01, HLA-A*33:01 | HPV51 (77.78%); HPV34,39,59,68,70 (88.89%); HPV52,16,18,31,33,35,45,56,58,66 (100.00%) | 100.00% (16/16) |
| 5 | LEIGRGQPL | HLA-B*40:01, HLA-B*44:03, HLA-B*44:02 | HPV16,34,35,39,51 (77.78%); HPV18,31,45,56,59,66,68,70 (88.89%); 52,33,58 (100.00%) | 100.00% (16/16) |
| 6 | ATILEDWQF | HLA-B*57:01, HLA-B*58:01, HLA-A*32:01, HLA-A*23:01, HLA-A*24:02, HLA-B*53:01, HLA-A*26:01 | HPV34,45,56,66,68 (55.56%); HPV18,31,35,51 (66.67%); HPV16,33,58,59 (77.78%); HPV52(100.00%) | 87.50% (14/16) |
| 7 | GLQARPKLK | HLA-A*03:01, HLA-A*30:01 | HPV16, 34, 35, 59 (55.56%); HPV31, 58 (66.67%); HPV33 (77.78%); HPV52 (100%) | 50.00% (8/16) |
| 8 | TSTAITCQK | HLA-A*68:01, HLA-A*11:01, HLA-A*03:01 | HPV45,59,70 (66.67%); HPV16,18,34,35,39,56,66,68 (77.78%); HPV31,33,58 (88.89%); HPV52(100%) | 93.75% (15/16) |
| 9 | KVSGLQYRV | HLA-A*02:06, HLA-A*02:01, HLA-A*02:03, HLA-A*32:01, HLA-A*68:02, HLA-A*30:01 | HPV18,39,45,51,56,59,66,68,70 (77.78%); HPV52,16,18,31,33,34,35,58 (100.00%) | 100.00% (16/16) |
| 10 | SASLEDTYR | HLA-A*68:01 | HPV16,18,34,45,56,59 (66.67%); HPV35,59 (77.78%); HPV31,33,39,51,58,68,70 (88.89%); HPV52(100%) | 100.00% (16/16) |
| L2 HPV52 | ||||
| 1 | LLKYGSLGV | HLA-A*02:03, HLA-A*02:01 | HPV16, 31, 35 (66.67%), HPV34, 58 (77.78%), HPV33 (88.89%), HPV52 (100%) | 43.75% (7/16) |
| 2 | VTVEPIGPL | HLA-A*68:02, HLA-A*26:01, HLA-A*02:06 | HPV16,18,31,34,35,39,45,59,68,70 (55.56%), HPV33,58 (66.67%), HPV52 (100%) | 81.25% (13/16) |
| 3 | ETTFIESGA | HLA-A*68:02 | HPV34, 58, 66 (55.56%), HPV16, 56 (66.67%), HPV33 (77.78%), HPV35 (88.89%), HPV52 (100%) | 50.00% (8/16) |
| 4 | STRHKRASA | HLA-A*30:01, HLA-B*08:01 | HPV18,51 (55.56%), HPV16,31,34,35,39,45,59,68,70 (66.67%), HPV56,66 (77.78%), HPV33,58 (88.89%), HPV52(100%) | 100.00% (16/16) |
| 5 | AGSGGRAGY | HLA-A*30:02 | HPV16,18,31,34,35,39,58,59,68,70 (66.67%), HPV33,45,51 (77.78%), HPV56,66 (88.89%), HPV52 (100%) | 100.00% (16/16) |
| 6 | VPLSTRPPT | HLA-B*07:02 | HPV34, 39,45,58,70 (55.56%), HPV33, 56, 66 (66, 67%), HPV16, 35 (77.78%), HPV31 (88.89%), HPV52 (100%) | 75.00% (12/16) |
| 7 | RPPVTVEPI | HLA-B*07:02, HLA-B*51:01 | HPV31,56,59,66 (55.56%), HPV16,18,33,39,45,58,68,70 (66.67%), HPV35(88.89%), HPV52 (100%) | 87.50% (14/16) |
| 8 | GVFFGGLGI | HLA-A*32:01 | HPV 56,66 (66.67%), HPV18,39,45,51,59,68,70 (77.78%), HPV35 (88.89%), HPV52,16,31,33,34,58 (100%) | 100.00% (16/16) |